Biotech

All Articles

Novo inks $600M NanoVation deal to study genetic medicines ex-liver

.Novo Nordisk is proceeding its push in to genetic medicines, accepting to compensate NanoVation The...

Innovent hyperlinks cytokine to colorectal cancer cells feedbacks

.Innovent Biologics has actually made the scenario that its gate inhibitor-cytokine blend protein ha...

Merck, Daiichi ADC attacks goal in stage 3 bronchi cancer research study

.A stage 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows AI center with collab to choose cancer intendeds

.Five months after Rakovina Therapies rotated toward artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medicine smash hits in phase 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, mentioning period 3 develo...

Despite ph. 3 overlook, Alkeus observes pathway ahead for eye disease property

.Though Alkeus Pharmaceuticals' oral eye condition resource fell short to substantially lower geogra...

Kairos goes social with $6M IPO to fund tests of cancer cells drug

.With a triad of biotechs striking the Nasdaq on Friday, it was actually easy to skip a smaller-scal...

Vaccine and also Keytruda combination efficient in squamous tissue cancer

.Invulnerable checkpoint preventions are actually the superheroes of cancer therapy. Medicines like ...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Regeneron's Opdualag competitor reveals 57% response rate

.Regeneron is actually back along with long-lasting consequence for its own LAG-3 inhibitor and PD-1...